OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antitumor activity of Z15-0-2, a bispecific nanobody targeting PD-1 and CTLA-4
J Zeng, Yuan Fang, Zixuan Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 29, pp. 2244-2252
Open Access | Times Cited: 6
J Zeng, Yuan Fang, Zixuan Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 29, pp. 2244-2252
Open Access | Times Cited: 6
Showing 6 citing articles:
Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 6
Single-Domain Antibodies as Antibody–Drug Conjugates: From Promise to Practice—A Systematic Review
Víctor Manuel Medina Pérez, Marta Baselga, Alberto J. Schuhmacher
Cancers (2024) Vol. 16, Iss. 15, pp. 2681-2681
Open Access | Times Cited: 4
Víctor Manuel Medina Pérez, Marta Baselga, Alberto J. Schuhmacher
Cancers (2024) Vol. 16, Iss. 15, pp. 2681-2681
Open Access | Times Cited: 4
Challenges and opportunities in single-domain antibody-based tumor immunotherapy
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Xiaozhi Xi, Guo Shu-hua, Yuchao Gu, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025), pp. 189284-189284
Closed Access
Nanobodies targeting the tumor microenvironment and their formulation as nanomedicines
Liudmyla Maksymova, Yannick A. Pilger, Lutz Nuhn, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Liudmyla Maksymova, Yannick A. Pilger, Lutz Nuhn, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Research progress on nanobodies in the diagnosis and treatment of natural toxin poisoning
Xiwei Wang, Zenglin Yin, Nan Liu, et al.
Nano Today (2025) Vol. 62, pp. 102711-102711
Closed Access
Xiwei Wang, Zenglin Yin, Nan Liu, et al.
Nano Today (2025) Vol. 62, pp. 102711-102711
Closed Access
Nanobodies as innovative immune checkpoint modulators: advancing cancer immunotherapy
Mohammad Hosseininejad-Chafi, Zohre Eftekhari, Akbar Oghalaie, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access
Mohammad Hosseininejad-Chafi, Zohre Eftekhari, Akbar Oghalaie, et al.
Medical Oncology (2024) Vol. 42, Iss. 1
Closed Access
